Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Akbar Pourfathollah

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Archives of Iranian Medicine|September 11, 2014
Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011Fatemeh Mohammadali, Ali Akbar Pourfathollah
Iranian Journal of Allergy, Asthma, and Immunology|March 20, 2012
CD40 and tolerance inductionMohammad Hossein Karimi, Ali Akbar Pourfathollah
Bioinformatics (Oxford, England)|May 13, 2022
rbioapi: user-friendly R interface to biologic web services' APIMoosa Rezwani, Ali Akbar Pourfathollah, Farshid Noorbakhsh
Virology Journal|February 1, 2017
Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of IranGharib Karimi, Maryam Zadsar, Ali Akbar Pourfathollah
Archives of Iranian Medicine|February 1, 2025
Urgent Alert: Potential Risk of Dengue Infection Transmission Through Blood Transfusion in IranZahra Taghinejad, Mohammad Asgharzadeh, Ali Akbar Pourfathollah
International Journal of Hematology-Oncology and Stem Cell Research|August 28, 2023
Voluntary Unpaid Plasma DonationAli Akbar Pourfathollah, Karim Shamsasenjan, Mahmoud Hadipour Dehshal
Hybridoma (2005)|March 3, 2009
An extreme strategy for the production of hybridomaReza Golestani, Ali Akbar Pourfathollah, Seyed Mohammad Moazzeni
Immunopharmacology and Immunotoxicology|September 29, 2018
Enhanced CD40 and ICOSL expression on dendritic cells surface improve anti-tumor immune responses; effectiveness of mRNA/chitosan nanoparticlesSaeed Daneshmandi, Ali Akbar Pourfathollah, Mehdi Forouzandeh-Moghaddam
Hybridoma (2005)|November 6, 2007
Cephalin as an efficient fusogen in hybridoma technology: can it replace poly ethylene glycol?Reza Golestani, Ali Akbar Pourfathollah, Seyed Mohammad Moazzeni
Hematology, Transfusion and Cell Therapy|January 10, 2021
Leukocyte reduction filters as an alternative source of peripheral blood leukocytes for researchShirin Ferdowsi, Zahra Abbasi-Malati, Ali Akbar Pourfathollah
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Archives of Iranian Medicine|September 11, 2014
Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011Fatemeh Mohammadali, Ali Akbar Pourfathollah
Iranian Journal of Allergy, Asthma, and Immunology|March 20, 2012
CD40 and tolerance inductionMohammad Hossein Karimi, Ali Akbar Pourfathollah
Bioinformatics (Oxford, England)|May 13, 2022
rbioapi: user-friendly R interface to biologic web services' APIMoosa Rezwani, Ali Akbar Pourfathollah, Farshid Noorbakhsh
Virology Journal|February 1, 2017
Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of IranGharib Karimi, Maryam Zadsar, Ali Akbar Pourfathollah
Archives of Iranian Medicine|February 1, 2025
Urgent Alert: Potential Risk of Dengue Infection Transmission Through Blood Transfusion in IranZahra Taghinejad, Mohammad Asgharzadeh, Ali Akbar Pourfathollah
International Journal of Hematology-Oncology and Stem Cell Research|August 28, 2023
Voluntary Unpaid Plasma DonationAli Akbar Pourfathollah, Karim Shamsasenjan, Mahmoud Hadipour Dehshal
Hybridoma (2005)|March 3, 2009
An extreme strategy for the production of hybridomaReza Golestani, Ali Akbar Pourfathollah, Seyed Mohammad Moazzeni
Immunopharmacology and Immunotoxicology|September 29, 2018
Enhanced CD40 and ICOSL expression on dendritic cells surface improve anti-tumor immune responses; effectiveness of mRNA/chitosan nanoparticlesSaeed Daneshmandi, Ali Akbar Pourfathollah, Mehdi Forouzandeh-Moghaddam
Hybridoma (2005)|November 6, 2007
Cephalin as an efficient fusogen in hybridoma technology: can it replace poly ethylene glycol?Reza Golestani, Ali Akbar Pourfathollah, Seyed Mohammad Moazzeni
Hematology, Transfusion and Cell Therapy|January 10, 2021
Leukocyte reduction filters as an alternative source of peripheral blood leukocytes for researchShirin Ferdowsi, Zahra Abbasi-Malati, Ali Akbar Pourfathollah
Pageof 14